Drug factory · FDA FEI 3009065969

Zhejiang Ausun Pharmaceutical Co., Ltd.

No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou, China

China: 1

Problems found, fixed voluntarily at FDA's last inspection, Apr 26, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2014: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
PosaconazoleMakes the active ingredient Hikma Pharmaceuticals USA Inc. 0054-0449

FDA inspection history

EndedResultProgramProblems noted
Apr 26, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
May 25, 2018No problems foundDrug Quality Assurance—
Oct 31, 2014Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: api manufacture.